Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

3.27
-0.1600-4.66%
Post-market: 3.300.0300+0.92%17:51 EST
Volume:2.08M
Turnover:7.03M
Market Cap:353.89M
PE:-1.46
High:3.57
Open:3.45
Low:3.26
Close:3.43
52wk High:13.35
52wk Low:2.19
Shares:108.22M
Float Shares:78.79M
Volume Ratio:0.66
T/O Rate:2.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2397
EPS(LYR):-2.7292
ROE:-74.88%
ROA:-40.56%
PB:1.13
PE(LYR):-1.20

Loading ...

Rocket Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 26

Chardan Cuts Price Target on Rocket Pharmaceuticals to $12 From $17, Keeps Buy Rating

MT Newswires Live
·
Jul 25

Rocket Pharmaceuticals Inc : Bofa Global Research Cuts to Neutral From Buy; Cuts Price Objective to $4 From $9

THOMSON REUTERS
·
Jul 25

BUZZ-U.S. STOCKS ON THE MOVE-Eaton, Karman, Mobileye Global

Reuters
·
Jul 25

BUZZ-U.S. STOCKS ON THE MOVE-Labcorp, Blackstone, L3Harris

Reuters
·
Jul 24

Rocket Pharmaceuticals Shares Down 3% on Delay of Certain Therapy Development Programs

THOMSON REUTERS
·
Jul 24

BUZZ-U.S. STOCKS ON THE MOVE-ServiceNow, PoolCorp, Rocket Pharma

Reuters
·
Jul 24

BUZZ-Rocket Pharma climbs after cutting workforce by 30%

Reuters
·
Jul 24

Rocket Pharmaceuticals Shares up 1.8% Premarket After Announcing Workforce Reduction, Restructuring Plans

THOMSON REUTERS
·
Jul 24

Rocket Pharmaceuticals Inc - Announces Corporate Reorganization - SEC Filing

THOMSON REUTERS
·
Jul 24

Rocket Pharmaceuticals Inc - FDA Approval of Rp-L102 Is No Longer Anticipated in 2026

THOMSON REUTERS
·
Jul 24

Rocket Pharmaceuticals Inc - to Reduce Headcount by 30%

THOMSON REUTERS
·
Jul 24

Rocket Pharmaceuticals Inc - Expects Cash Runway Into Q2 2027

THOMSON REUTERS
·
Jul 24

Rocket Pharmaceuticals : Restructuring Pipeline to Focus on Aav Cardiovascular Platform and Regulatory Activities for Kresladi

THOMSON REUTERS
·
Jul 24

Rocket Pharmaceuticals : Reduction in Workforce & Other Planned Cost-Saving Initiatives, to Reduce Co's 12-Month Operating Expenses by Nearly 25%

THOMSON REUTERS
·
Jul 24

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

THOMSON REUTERS
·
Jul 24

Rocket Pharmaceuticals Inc - to Reduce Workforce by 30% - SEC Filing

THOMSON REUTERS
·
Jul 24

Rocket Pharmaceuticals Announces Strategic Reorganization with 30% Workforce Reduction to Cut Operating Expenses by 25%

Reuters
·
Jul 24

Securities Class Action Filed Against Rocket Pharmaceuticals Over Alleged Misstatements and Omissions

Reuters
·
Jul 24

Rocket Pharmaceuticals Up Nearly 18%, on Pace for Largest Percent Increase Since September 2023 -- Data Talk

Dow Jones
·
Jul 18